Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Duration: February 1, 2020
to
present
General Issues: Health Issues , Pharmacy , Telecommunications , Consumer Issues/Safety/Protection
Spending: about $1,165,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: U.S. Senate, House of Representatives, Food & Drug Administration (FDA), Office of Management & Budget (OMB)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Sarah-Lloyd Stevenson Legislative Assistant, Sen. Roger Wicker (R-MS); Policy Advisor, HHS Office of the Secretary; Policy Advisor, Executive Office of the President (No lobbying of Executive Branch officials)
Legislative Assistant, Sen. Roger Wicker (R-MS); Policy Advisor, HHS Office of the Secretary; Policy Advisor, Executive Office of the President (House and Senate lobbying only. No lobbying of Executive Branch officials.)
Ryan Shay Leg. Dir., Rep. Susie Lee (D-NV); Sr. Leg. Asst & Leg. Asst, Rep. Andre Carson (D-IN); Leg. Aide & Leg. Corrs., Sen. Maria Cantwell (D-WA); Staff Asst, Senate Committee on Energy & Natural Resources
Legislative Director, Rep. Susie Lee (D-NV), May 2021 - December 2021; Senior Legislative Assistant & Legislative Assistant, Rep. Andre Carson (D-IN), April 2019 - May 2021; Legislative Aide & Legislative Correspondent, Sen. Maria Cantwell (D-WA)
Elliot Vice Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010
Elizabeth Baney n/a
Beena Patel n/a
Nisha Quasba n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $20,000. The report was filed on April 19.
Original Filing: 301564967.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
4th Quarter, 2023
In Q4, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $70,000. The report was filed on Jan. 22.
Original Filing: 301537562.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
3rd Quarter, 2023
In Q3, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $80,000. The report was filed on Oct. 16, 2023.
Original Filing: 301501162.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
2nd Quarter, 2023
In Q2, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $80,000. The report was filed on July 19, 2023.
Original Filing: 301482170.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
1st Quarter, 2023
In Q1, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $80,000. The report was filed on April 19, 2023.
Original Filing: 301456077.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 -SHOP SAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
4th Quarter, 2022
In Q4, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $80,000. The report was filed on Jan. 18, 2023.
Original Filing: 301430124.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety;Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOP SAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOP SAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
3rd Quarter, 2022
In Q3, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $80,000. The report was filed on Oct. 20, 2022.
Original Filing: 301419063.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety;Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOP SAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOP SAFE Act; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
2nd Quarter, 2022
In Q2, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $80,000. The report was filed on July 18, 2022.
Original Filing: 301383159.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; STOP Act implementation; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); S. 1843, H.R. 3429 - SHOP SAFE Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; STOP Act implementation; S. 1843, H.R. 3429 - SHOP SAFE Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
1st Quarter, 2022
In Q1, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $80,000. The report was filed on April 19, 2022.
Original Filing: 301363275.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability regarding COVID-19 frauds; STOP Act implementation; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability regarding COVID-19 frauds; STOP Act implementation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
4th Quarter, 2021
In Q4, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $70,000. The report was filed on Jan. 10, 2022.
Original Filing: 301321010.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability regarding COVID-19 frauds; STOP Act implementation; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability regarding COVID-19 frauds; STOP Act implementation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
3rd Quarter, 2021
In Q3, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $60,000. The report was filed on Oct. 20, 2021.
Original Filing: 301313909.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability regarding COVID-19 frauds; STOP Act implementation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act; Section 230 reform.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
2nd Quarter, 2021
In Q2, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $65,000. The report was filed on July 20, 2021.
Original Filing: 301284604.xml
Lobbying Issues
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability regarding COVID-19 frauds; STOP Act implementation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
WHOIS; Communications Decency Act, Section 230 reform.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021.
Agencies Lobbied
U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
1st Quarter, 2021
In Q1, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $70,000. The report was filed on April 16, 2021.
Original Filing: 301254632.xml
Lobbying Issues
Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety; domain name system accountability regarding COVID-19 frauds; WHOIS; Communications Decency Act, Section 230 reform; STOP Act implementation.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $70,000. The report was filed on Jan. 19, 2021.
Original Filing: 301235283.xml
Lobbying Issues
Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety; domain name system accountability regarding COVID-19 frauds; WHOIS; Communications Decency Act, Section 230 reform; STOP Act implementation
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $70,000. The report was filed on Oct. 19, 2020.
Original Filing: 301213978.xml
Lobbying Issues
Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety; domain name system accountability regarding COVID-19 frauds; WHOIS; Communications Decency Act, Section 230 reform
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $70,000. The report was filed on July 17, 2020.
Original Filing: 301190502.xml
Lobbying Issues
Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety; domain name system accountability regarding COVID-19 frauds; WHOIS
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Faegre Drinker Biddle & Reath LLP lobbied for Alliance for Safe Online Pharmacies (ASOP Global) , earning $40,000. The report was filed on April 20, 2020.
Original Filing: 301177535.xml
Lobbying Issues
Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety; domain name system accountability regarding COVID-19 frauds; WHOIS
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
Faegre Drinker Biddle & Reath LLP filed a lobbying registration on April 18, 2020 to represent Alliance for Safe Online Pharmacies (ASOP Global), effective Feb. 1, 2020.
Original Filing: 301171733.xml
Issue(s) they said they’d lobby about: Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety; domain name system accountability regarding COVID-19 frauds; WHOIS .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...